Retraction notice reveals concerns over non-original data, questioning the impact of VEGF189 neural stem cells on motor outcomes in spinal cord injury.
Retraction Notice: This publication has been retracted by the Editor due to the identification of non-original figure images and manuscript content that raise concerns regarding the credibility and originality of the study and the manuscript. Reference: Yun Zeng, Heng Han, Bing Tang, Jie Chen, Dan Mao, Min Xiong. Transplantation of Recombinant Vascular Endothelial Growth Factor (VEGF)189-Neural Stem Cells Downregulates Transient Receptor Potential Vanilloid 1 (TRPV1) and Improves Motor Outcome in Spinal Cord Injury. Med Sci Monit, 2018; 24: 1089-1096. DOI: 10.12659/MSM.905264.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: